Literature DB >> 33444596

Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice.

Hui Shen1, Kai Chen2, Rosa Anna M Marino3, Ross A McDevitt4, Zheng-Xiong Xi5.   

Abstract

Methamphetamine (METH) is a highly addictive psychostimulant. The continuous use of METH may lead to its abuse and neurotoxicity that have been associated with METH-induced increases in release of dopamine (DA) and glutamate in the brain. METH action in DA has been shown to be mediated by redistribution of DA from vesicles into cytoplasm via vesicular monoamine transporter 2 (VMAT2) and the subsequent reversal of membrane DA transporter (DAT), while little is known about the mechanisms underlying METH-induced glutamate release. Recent studies indicate that a subpopulation of midbrain DA neurons co-expresses VMAT2 and vesicular glutamate transporter 2 (VGLUT2). Therefore, we hypothesized that METH-induced glutamate release may in part originate from such a dual phenotype of DA neurons. To test this hypothesis, we used Cre-LoxP techniques to selectively delete VGLUT2 from midbrain DA neurons, and then examined nucleus accumbens (NAc) DA and glutamate responses to METH using in vivo brain microdialysis between DA-VGLUT2-KO mice and their VGLUT2-HET littermates. We found that selective deletion of VGLUT2 from DA neurons did not significantly alter basal levels of extracellular DA and glutamate, but attenuated METH-induced increases in extracellular levels of DA and glutamate. In addition, DA-VGLUT2-KO mice also displayed lower locomotor response to METH than VGLUT2-HET control mice. These findings, for the first time, suggest that cell-type specific VGLUT2 expression in DA neurons plays an important role in the behavioral and neurochemical effects of METH. Glutamate corelease from DA neurons may in part contributes to METH-induced increase in NAc glutamate release.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Accumbent; Dopamine; Glutamate; Methamphetamine; VGLUT2; VMAT2

Mesh:

Substances:

Year:  2021        PMID: 33444596      PMCID: PMC9354859          DOI: 10.1016/j.pbb.2021.173104

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.697


  52 in total

1.  Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice.

Authors:  Johan Alsiö; Karin Nordenankar; Emma Arvidsson; Carolina Birgner; Souha Mahmoudi; Briac Halbout; Casey Smith; Guillaume M Fortin; Lars Olson; Laurent Descarries; Louis-Éric Trudeau; Klas Kullander; Daniel Lévesque; Asa Wallén-Mackenzie
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

Review 2.  The neurocircuitry involved in oxytocin modulation of methamphetamine addiction.

Authors:  Sarah J Baracz; Jennifer L Cornish
Journal:  Front Neuroendocrinol       Date:  2016-08-18       Impact factor: 8.606

Review 3.  Complementary distribution of vesicular glutamate transporters in the central nervous system.

Authors:  Takeshi Kaneko; Fumino Fujiyama
Journal:  Neurosci Res       Date:  2002-04       Impact factor: 3.304

4.  Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties.

Authors:  Kätlin Silm; Jing Yang; Pamela F Marcott; Cedric S Asensio; Jacob Eriksen; Daryl A Guthrie; Amy H Newman; Christopher P Ford; Robert H Edwards
Journal:  Neuron       Date:  2019-04-16       Impact factor: 17.173

5.  Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons.

Authors:  Stephan Lammel; Elizabeth E Steinberg; Csaba Földy; Nicholas R Wall; Kevin Beier; Liqun Luo; Robert C Malenka
Journal:  Neuron       Date:  2015-01-21       Impact factor: 17.173

6.  Developmental and target-dependent regulation of vesicular glutamate transporter expression by dopamine neurons.

Authors:  Jose Alfredo Mendez; Marie-Josée Bourque; Gregory Dal Bo; Mathieu L Bourdeau; Marc Danik; Sylvain Williams; Jean-Claude Lacaille; Louis-Eric Trudeau
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

7.  Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice.

Authors:  Zongsheng He; Lingdi Yan; Zheng Yong; Zhaoqi Dong; Huajin Dong; Zehui Gong
Journal:  Behav Brain Res       Date:  2012-11-14       Impact factor: 3.332

Review 8.  Pharmacotherapy of methamphetamine addiction: an update.

Authors:  Ahmed Elkashef; Frank Vocci; Glen Hanson; Jason White; Wendy Wickes; Jari Tiihonen
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

Review 9.  Glutamate co-transmission as an emerging concept in monoamine neuron function.

Authors:  Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

10.  Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.

Authors:  Zachary Freyberg; Mark S Sonders; Jenny I Aguilar; Takato Hiranita; Caline S Karam; Jorge Flores; Andrea B Pizzo; Yuchao Zhang; Zachary J Farino; Audrey Chen; Ciara A Martin; Theresa A Kopajtic; Hao Fei; Gang Hu; Yi-Ying Lin; Eugene V Mosharov; Brian D McCabe; Robin Freyberg; Kandatege Wimalasena; Ling-Wei Hsin; Dalibor Sames; David E Krantz; Jonathan L Katz; David Sulzer; Jonathan A Javitch
Journal:  Nat Commun       Date:  2016-02-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.